PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12939720-9	2003	Daclizumab, infliximab, visilizumab, and ABX-CBL have shown promising activity in steroid-resistant acute GvHD in early clinical testing.	Steroids	82-89	Cbl proto-oncogene	Homo sapiens	45-48	
11567989-0	2001	Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL.	Steroids	13-20	Cbl proto-oncogene	Homo sapiens	104-107	
16180173-10	1999	In a clinical trial, ABX-CBL was administered to ten patients with acute steroid-resistant GvHD.	Steroids	73-80	Cbl proto-oncogene	Homo sapiens	25-28